4

OWNERSHIP DOCUMENT

Company: Inhibitor Therapeutics, Inc.
Filed: November 15, 2016
Period of Report: November 15, 2016
Accession Number: 0001144204-16-134828

View Document ↗ View on SEC.gov ↗